Compare CERT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERT | INSP |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2018 |
| Metric | CERT | INSP |
|---|---|---|
| Price | $6.97 | $50.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $11.67 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 4.6M | 1.1M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 87.50 | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,838,000.00 | $82,050,000.00 |
| Revenue This Year | $4.18 | $8.02 |
| Revenue Next Year | $5.39 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.75 | ★ 62.18 |
| 52 Week Low | $4.45 | $38.91 |
| 52 Week High | $13.88 | $147.03 |
| Indicator | CERT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 63.20 |
| Support Level | $5.93 | $48.30 |
| Resistance Level | $7.46 | $58.45 |
| Average True Range (ATR) | 0.41 | 2.28 |
| MACD | 0.03 | 0.58 |
| Stochastic Oscillator | 79.40 | 81.23 |
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.